✦ LIBER ✦

Annual cost of bevacizumab in the adjuvant treatment of ovarian cancer to the U.S. Medicare system

✍ Scribed by A. Walter; K. Manahan; D. Labarge; G. Phibbs; J. Geisler

Book ID: 113963591
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 60 KB
Volume: 125
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2011.12.036

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Annual cost of bevacizumab in the adjuva

Annual cost of bevacizumab in the adjuvant treatment of ovarian cancer to the U.S. Medicare system

✍ A. Walter; J. Geisler; K. Manahan 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 78 KB

Bevacizumab in the Treatment of Ovarian

Bevacizumab in the Treatment of Ovarian Cancer

✍ Florian Heitz, Philipp Harter, Jana Barinoff, Bianca Beutel, Paevi Kannisto, Jac 📂 Article 📅 2012 🏛 Springer Healthcare Communications 🌐 English ⚖ 963 KB

Evaluation of Bevacizumab in the Adjuvan

Evaluation of Bevacizumab in the Adjuvant Treatment of Colon Cancer

✍ Leonard Saltz 📂 Article 📅 2010 🏛 Current Science Inc. 🌐 English ⚖ 64 KB

Cost-effectiveness of a predictive bioma

Cost-effectiveness of a predictive biomarker for bevacizumab responsiveness in the primary treatment of ovarian cancer

✍ J. Barnett; A. Alvarez-Secord; D. Cohn; C. Leath; B. Peterson; E. Myers; L. Havr 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 133 KB

Incorporation of Bevacizumab in the Prim

Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer

✍ Burger, Robert A.; Brady, Mark F.; Bookman, Michael A.; Fleming, Gini F.; Monk, 📂 Article 📅 2011 🏛 Massachusetts Medical Society 🌐 English ⚖ 690 KB

Caution in Adding Bevacizumab in the Adj

Caution in Adding Bevacizumab in the Adjuvant Treatment of Breast Cancer

✍ Dimosthenis Ziogas; Dimitrios Roukos 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 134 KB